Capital structure refers to the mix of funding sources a company uses to finance its assets and its operations. The sources typically can be bucketed into equity and debt. Using internally ...

In HER2-positive early breast cancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival versus Herceptin. Among patients with HER2-positive early breast ...

Wrexham co-chairmen Rob McElhenney and Ryan Reynolds. / PA Images/IMAGO Wrexham A.F.C.—one of the oldest clubs in world soccer—have experienced a remarkable revival both on and off the pitch ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. When my co-founder and I started Invoice Home, we wanted to build a business that could ...

When you first enter a new world, you can either spawn near a structure or find one while exploring any of the three dimensions. While finding some can be quite easy, others are extremely hard to ...

A divisional organizational structure consists of parallel divisions, or operating units. These division might be responsible for a product or service, a geographical location, or a customer group ...

Organizing tasks and employees produces a company structure. "Mechanistic" describes the strictest and most formal of these structures. A mechanistic organization has fine divisions of labor ...

The combo drug, Kadcyla, is already approved to treat patients with advanced HER2-positive breast cancer, researchers said. The new results show that Stage 1 breast cancer patients who received ...

Archaeologists on the Greek island of Crete have uncovered a monumental ancient structure that threatens to halt progress on the construction of a new airport. The structure belonged to the Minoan ...

Phase III KATHERINE results reinforce Kadcyla as the standard of care for this population, with more than 82,000 people treated to date1,2Long-term data also showed continued benefit in invasive ...

A statistically significant and clinically meaningful improvement in overall survival (OS), a secondary endpoint, was observed with adjuvant (post-surgery) Kadcyla® (ado-trastuzumab emtansine ...